CRITICALFEDAesthetic Injectables2026-06-23
FDA import refusal: ONABOTULINUMTOXINA (South Korea)
FDA refuses entry of ONABOTULINUMTOXINA from South Korea.
What to do
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
FDA Import Refusal · primary source ↗
Related alerts
- FDA import refusal: TRIAMCINOLONE (GLUCOCORTICOID) (Guatemala)
- FDA import refusal: LIDOCAINE HCL (ANESTHETIC) (South Korea)
- FDA import refusal: IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE (South Korea)
- FDA import refusal: LIDOCAINE (China)
- FDA import refusal: IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE (South Korea)
Monitoring, not legal advice.